SCHEMBL961666

SCHEMBL961666

OC1(CCCl)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14842231 0.81
SCHEMBL21641037 0.73
SCHEMBL14128934 0.67 ESR2 (0.41)
SCHEMBL128734 0.67
SCHEMBL131068 0.67
SCHEMBL17669283 0.67
SCHEMBL1103929 0.67
SCHEMBL373953 0.65
SCHEMBL22482038 0.63
SCHEMBL3896263 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11459336-B2 Pyrazine carbamates and their use as GluN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2022-10-04 US disclosed
EP-3983072-A1 PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS Janssen Pharmaceutica NV (BE) 2022-04-20 EP disclosed
CN-113950357-A Pyrazine carbamates and their use as GluN2B receptor modulators 詹森药业有限公司 2022-01-18 CN disclosed
CN-105732382-B Intermediates and processes for preparing 4-alkyl-3-methylenylbutyl carboxylates 信越化学工业株式会社 2021-03-09 CN disclosed
US-20200392155-A1 PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-12-17 US disclosed
WO-2020249796-A1 PYRAZINE CARBAMATES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2020-12-17 WO disclosed
EP-3037404-B1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE SHINETSU CHEMICAL CO (JP) 2018-08-29 EP disclosed
US-9688622-B1 1-(2-acyloxyethyl)cyclopropyl sulfonate compound, 3-halomethyl-3-butenyl carboxylate compound, and method for producing 4-alkyl-3-methylenebutyl carboxylate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-27 US disclosed
US-9688622-B1 1-(2-acyloxyethyl)cyclopropyl sulfonate compound, 3-halomethyl-3-butenyl carboxylate compound, and method for producing 4-alkyl-3-methylenebutyl carboxylate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-27 US disclosed
US-9688622-B1 1-(2-acyloxyethyl)cyclopropyl sulfonate compound, 3-halomethyl-3-butenyl carboxylate compound, and method for producing 4-alkyl-3-methylenebutyl carboxylate SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-06-27 US disclosed
US-20160185708-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-30 US disclosed
US-20160185708-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-30 US disclosed
US-20160185708-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-06-30 US disclosed
EP-3037404-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE Shin-Etsu Chemical Co., Ltd. (JP) 2016-06-29 EP disclosed
EP-3037404-A1 1-(2-ACYLOXYETHYL)CYCLOPROPYL SULFONATE COMPOUND, 3-HALOMETHYL-3-BUTENYL CARBOXYLATE COMPOUND, AND METHOD FOR PRODUCING 4-ALKYL-3-METHYLENEBUTYL CARBOXYLATE Shin-Etsu Chemical Co., Ltd. (JP) 2016-06-29 EP disclosed
EP-2379553-B1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL MYERS SQUIBB CO (US) 2013-06-26 EP disclosed
US-8349880-B2 Bicyclic compounds for the reduction of beta-amyloid production BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-08 US disclosed
EP-2379553-A1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION Bristol-Myers Squibb Company (US) 2011-10-26 EP disclosed
US-20110015175-A1 Bicyclic Compounds for the Reduction of Beta-Amyloid Production BRISTOL-MYERS SQUIBB COMPANY 2011-01-20 US disclosed
WO-2010083141-A1 BICYCLIC COMPOUNDS FOR THE REDUCTION OF BETA-AMYLOID PRODUCTION BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-22 WO disclosed